
Myongji Hospital doctor contributes to landmark study on breakthrough liver cancer treatment
Park Joong-won, a professor of gastroenterology at Myongji Hospital, has contributed to an international phase 3 study showing that a new immuno-oncology combination therapy improves survival and tumor reduction in hepatocellular carcinoma (HCC) compared …